{"id":"NCT02680756","sponsor":"Shield Therapeutics","briefTitle":"Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD","officialTitle":"A Phase 3b, Randomized, Controlled, Multicentre Study With Oral Ferric Maltol (Feraccru) or Intravenous Iron (Ferric Carboxy Maltose; FCM), for the Treatment of Iron Deficiency Anaemia in Subjects With Inflammatory Bowel Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01","primaryCompletion":"2018-10","completion":"2019-01","firstPosted":"2016-02-11","resultsPosted":"2020-02-24","lastUpdate":"2020-11-02"},"enrollment":250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia, Iron-Deficiency","Inflammatory Bowel Disease","Crohn's Disease"],"interventions":[{"type":"DRUG","name":"Ferric Maltol","otherNames":["Feraccru","Ferric Trimaltol","ST10","ST10-01"]},{"type":"DRUG","name":"Ferric Carboxy Maltose","otherNames":[]}],"arms":[{"label":"Oral ferric iron compound","type":"EXPERIMENTAL"},{"label":"Intravenous iron","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).","primaryOutcome":{"measure":"Number of Subjects Achieving Either a 2g/dL Increase in Hb OR Normalization of Hb at Week 12","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"Oral Ferric Iron Compound","deltaMin":84,"sd":null},{"arm":"Intravenous Iron","deltaMin":105,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.298"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":44,"countries":["United States","Belgium","France","Germany","Hungary","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":127},"commonTop":["Gastrointestinal disorders","Infections and infestations","Abdominal pain","General disorders and administration site conditions","Nasopharyngitis"]}}